Viewing Study NCT03267316

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT03267316
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2017-08-24
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Sponsor: Cantargia AB
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
None Pancreatic Ductal Adenocarcinoma View
None Triple Negative Breast Cancer View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None First-in-Human View
None Phase 1 View
None Phase 2 View
None Antibody, Monoclonal View
None IL1RAP View
None Safety View
None Tolerability View
None Cancer View
None Solid tumor View
None Malignant View
None Dose escalation View
None Dose expansion View
None CAN04 View
None Immunoglobulin View
None Clinical Trial View
None Infusion View
None Antineoplastic View
None Anticancer View